Movement Disorders (revue) - Exploration (Accueil)

Index « Titre (en) » - entrée « drug »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
drs < drug < drugs  Facettes :

List of bibliographic references indexed by drug

Number of relevant bibliographic references: 76.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000170 (2015) Javier Pagonabarraga [Espagne] ; Saul Martinez-Horta [Espagne] ; Ram N Fernández De Bobadilla [Espagne] ; Jesús Pérez [Espagne] ; Roser Ribosa-Nogué [Espagne] ; Juan Marín [Espagne] ; Berta Pascual-Sedano [Espagne] ; Carmen García [Espagne] ; Alexandre Gironell [Espagne] ; Jaime Kulisevsky [Espagne]Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.
000193 (2015) Stanley Fahn [États-Unis] ; Werner Poewe [Autriche]Levodopa: 50 years of a revolutionary drug for Parkinson disease.
000320 (2015) Chrystalina A. Antoniades [Royaume-Uni] ; Nele Demeyere [Royaume-Uni] ; Christopher Kennard [Royaume-Uni] ; Glyn W. Humphreys [Royaume-Uni] ; Michele T. Hu [Royaume-Uni]Antisaccades and executive dysfunction in early drug-naive Parkinson's disease: The discovery study.
000428 (2014) Roberto Cilia [Italie] ; Giorgio Marotta ; Alice Belletti ; Chiara Siri ; Gianni PezzoliReversible dopamine transporter reduction in drug-induced Parkinsonism.
000D35 (2012) Philipp Mahlknecht ; Heike Stockner ; Stefan Kiechl ; Johann Willeit ; Verena Rastner ; Arno Gasperi ; Gregor Rungger ; Werner Poewe [Autriche] ; Klaus SeppiIs transcranial sonography useful to distinguish drug-induced parkinsonism from Parkinson's disease?
001157 (2012) Donald L. Bliwise [États-Unis] ; Lynn Marie Trotti [États-Unis] ; Anthony G. Wilson [États-Unis] ; Sophia A. Greer [États-Unis] ; Cathy Wood-Siverio [États-Unis] ; Jorge J. Juncos [États-Unis] ; Stewart A. Factor [États-Unis] ; Alan Freeman [États-Unis] ; David B. Rye [États-Unis]Daytime Alertness in Parkinson's Disease: Potentially Dose-Dependent, Divergent Effects by Drug Class
001315 (2011) Magdalena Eriksson Domellöf [Suède] ; Eva Elgh [Suède] ; Lars Forsgren [Suède]The relation between cognition and motor dysfunction in drug‐naive newly diagnosed patients with Parkinson's disease
001332 (2011) Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni]The effect of drug treatment on neurogenesis in Parkinson's disease
001623 (2011) Angelo Antonini [Italie] ; Chiara Siri [Italie] ; Gabriella Santangelo [Italie] ; Roberto Cilia [Italie] ; Michele Poletti [Italie] ; Margherita Canesi [Italie] ; Alessandra Caporali [Italie] ; Francesca Mancini [Italie] ; Gianni Pezzoli [Italie] ; Roberto Ceravolo [Italie] ; Ubaldo Bonuccelli [Italie] ; Paolo Barone [Italie]Impulsivity and compulsivity in drug‐naïve patients with Parkinson's disease
001688 (2011) Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France
001888 (2011) Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France
001964 (2010) Lynn Rochester [Royaume-Uni] ; Danny Rafferty [Royaume-Uni] ; Catherine Dotchin [Royaume-Uni] ; Oliva Msuya ; Victor Minde ; R. W. Walker [Royaume-Uni]The effect of cueing therapy on single and dual‐task gait in a drug naïve population of people with Parkinson's disease in northern Tanzania
001A29 (2010) Caspar Stephani [Allemagne] ; Claudia Trenkwalder [Allemagne]Rhabdomyolysis after low‐dose quetiapine in a patient with Parkinson's disease with drug‐induced psychosis: A case report
001B56 (2010) Szu-Chia Lai ; Shih-Ming Jung [Taïwan] ; Padraic Grattan-Smith [Australie] ; Ella Sugo [Australie] ; Yen-Wen Lin [Taïwan] ; Rou-Shayn Chen ; Chiung-Chu Chen ; Yah-Huei Wu-Chou [Taïwan] ; Anthony E. Lang [Canada] ; Chin-Song LuNeuronal intranuclear inclusion disease: Two cases of dopa‐responsive juvenile parkinsonism with drug‐induced dyskinesia
001B75 (2010) Victor Peralta [Espagne] ; Maria S. Campos [Espagne] ; Elena García De Jal N [Espagne] ; Manuel J. Cuesta [Espagne]Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders
001D30 (2010) Amitabh Gupta [Canada] ; Anthony E. Lang [Canada]Drug‐induced cranial myoclonus
001D73 (2010) Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni]Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward
001D81 (2010) Flavio Nobili [Italie] ; Claudio Campus [Italie] ; Dario Arnaldi [Italie] ; Fabrizio De Carli [Italie] ; Gaia Cabassi [Italie] ; Andrea Brugnolo [Italie] ; Barbara Dessi [Italie] ; Silvia Morbelli [Italie] ; Gianmario Sambuceti [Italie] ; Giovanni Abbruzzese [Italie] ; Guido Rodriguez [Italie]Cognitive‐nigrostriatal relationships in de novo, drug‐naïve Parkinson's disease patients: A [I‐123]FP‐CIT SPECT study
001E61 (2010) Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database
001F72 (2010) Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Adverse Drug Reactions to Dopamine Agonists: A Comparative Study in the French Pharmacovigilance Database
002341 (2009) Rachel E. Salas [États-Unis] ; Richard P. Allen [États-Unis] ; Christopher J. Earley [États-Unis] ; Charlene E. Gamaldo [États-Unis]Drug hoarding: A case of atypical dopamine dysregulation syndrome in a RLS patient

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "drug" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "drug" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    drug
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024